Comparing two techniques for treating persistent atrial fibrillation
Official title: Comparison Between VEin of MArshall Ethanol Infusion Versus Extended Pulmonary Vein PULSEd Field Ablation After Failed Pulmonary Vein Isolation in Patients with Persistent Atrial Fibrillation
Run by AZ Sint-Jan AV · NCT06383975 · Data updated 2026-11-12
This study is testing two different ways to treat ongoing atrial fibrillation to see which method works better at keeping heart rhythms steady.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | AZ Sint-Jan AV Academic / other |
| Locations | 1 site (Bruges) |
| Status | Recruiting |
| Started | May 15, 2024 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | October 9, 2024 |
| Trial ID | NCT06383975 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals experiencing symptomatic persistent atrial fibrillation despite having undergone a previous pulmonary vein isolation procedure.
✕Probably not a fit
Patients with persistent atrial fibrillation lasting more than 12 months or those with significant heart conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare two different ablation techniques for patients suffering from persistent atrial fibrillation, a condition characterized by irregular and rapid heart rhythms. One technique uses pulsed field energy to create scars in the heart, while the other employs traditional radiofrequency ablation. Participants will undergo one of these procedures and will be monitored for one year to assess the effectiveness of each method in preventing the recurrence of atrial fibrillation. Regular check-ups and heart rhythm monitoring will be conducted to gather data on the outcomes.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients with persistent atrial fibrillation, potentially reducing the recurrence of their condition.
How similar studies have gone: Other studies have shown promise with similar ablation techniques, but this specific comparison of pulsed field ablation and ethanolization is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptomatic persistent atrial fibrillation (AF) despite a first PVI. Persistent AF is defined as the presence of AF lasting ≥7 days (i.e. in case of new onset AF one has to wait for 7 days) Exclusion Criteria: * Persistent AF lasting ≥ 12 months * Advanced valvular heart disease * Left atrial (LA) volume \>150mL * LA diameter (PS-LAX) \>60mm * Septal wall diameter \>15mm * Life expectancy \<1 year * Weight \>150 kg * Any contra indication to catheter ablation
Where it's running
-
AZ Sint-Jan Brugge AV
Bruges, Belgium Recruiting
Study contacts
- Principal investigator: Sébastien Knecht, MD, PhD — AZ Sint-Jan Brugge AV
- Study coordinator: Emma Christiaen
- Email: emma.christiaen@azsintjan.be
- Phone: 003250453293
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FARAFLEX Mapping and Pulsed Field Ablation for Atrial Fibrillation
This trial tests the FARAFLEX Mapping and PFA System to see if it can safely help adults with drug-refractory paroxysmal or persistent atrial fibrillation.
-
Pulsed field ablation for atrial fibrillation in underrepresented minority patients
This registry will test how well Boston Scientific pulsed field ablation works and how safe it is for Black, Hispanic, Asian, and other underrepresented adults with paroxysmal or persistent atrial fibrillation.
-
Left Atrial Appendage Occlusion and Rhythm Restoration in AF Patients
This trial tests a combined procedure using the Volt PFA System and Amulet 2 to see if it safely and feasibly treats atrial fibrillation while also closing the left atrial appendage in adults with AF.
-
Qidong Yixin Granules to prevent atrial fibrillation returning after ablation
This trial tests whether taking Qidong Yixin Granules after catheter ablation can lower the chance of atrial fibrillation coming back within a year in adults with persistent AF.
-
FARAPULSE pulsed-field waveform treatment for paroxysmal and persistent atrial fibrillation
This will test new pulsed electrical waveforms delivered by the FARAPULSE PFA system to treat adults with paroxysmal or persistent atrial fibrillation.
-
PVI Alone vs PVI Plus PWI and SVCI with PFA in Persistent AF
This study tests whether adding posterior wall isolation and superior vena cava isolation to pulmonary vein isolation with pulsed-field ablation helps people with persistent atrial fibrillation stay in rhythm.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.